Sep 2026· Small Methods· Vol 10, pp. e71075 - e71075· 0 citations· 36 references
Medicine
Abstract
The programmability of CRISPR-Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non-nucleic-acid targets remains highly desirable. Here, we report a universal split-activator strategy that enables programmable Cas12a activation in response to a small molecule and a protein. In this approach, a canonical activator is divided into two fragments (p1 and p2), such that Cas12a activation occurs only upon their simultaneous assembly. We integrate this mechanism with aptamer-mediated conformation switching, wherein target binding destabilizes an aptamer-p2 duplex, releasing p2 to complete the activator complex and trigger Cas12a nuclease activity. Using this design, we demonstrate selective recognition of the small-molecule metabolite adenosine and the protein biomarker prostate-specific antigen (PSA), with high specificity against structurally related controls. Signal generation is achieved using fluorescent DNA nanoclusters (DFN-1), which undergo fluorescence decrease upon Cas12a-mediated degradation. The system exhibits concentration-dependent responses for both targets. Together, this work establishes a modular framework for coupling aptamer-based molecular recognition to programmable Cas12a activation, expanding the functional scope of CRISPR systems beyond nucleic acids and enabling new opportunities in CRISPR-Cas12a-mediated detection.
SPRINT-Cas12a provides a single-probe, dual-pathway strategy for Cas12a-mediated miRNA detection and shows promise for portable molecular diagnostics and point-of-care testing.
Qian Li, Jun-Da Liu, Mo Xue et al.· Analytical Chemistry· 0 citations
DACAR provides a unified, programmable framework for precise molecular-level control of Cas13a, advancing its potential in diagnostics and molecular logic.
Chang-Qing Wan, Wen-Zheng Liu, Shu-Tao Pan et al.· Biosensors & bioelectronics· 0 citations
Most existing CRISPR/Cas12a methods for small molecules detection employ DNA aptamers as an intermediary, while RNA aptamers remain underexplored. The conventional CRISPR/Cas12 system offers limited programmability due to its partially conserved crRNA sequence. In this study, we developed an aptamer-regulated CRISPR/Ca...
Jin-Ming Liu, Le Li, Zi-Wen Tang et al.· Analytical Methods· 0 citations
CRISPR-Cas12a holds great promise for molecular diagnostics and gene editing due to its sequence-specific DNA recognition and robust trans-cleavage activity, yet precise tuning of its nuclease activity remains challenging. Herein, we report a simple temperature-regulation strategy using cost-effective ssDNA blockers, t...
A CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA, enabling Mn2+-responsive control over its trans-cleavage activity for nucleic-acid-amplification-free detection and establishing a powerful platform for biosensing.
Messenger RNA (mRNA) has emerged as a powerful tool for developing new therapeutics and biotechnologies due to its inherent ability to express proteins. However, the lack of precise control over protein expression remains a critical limitation for mRNA-based biomedical applications. Herein, we developed a novel photo...
Sheng Li, Han Li, Yu-Ling Teng et al.· JACS Au· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.